Association of plasma fibrinogen level with the severity of obstructive sleep apnoea patients in a tertiary care hospital
DOI:
https://doi.org/10.18203/2320-6012.ijrms20241530Keywords:
Obstructive sleep apnoea, Arterial hypoxemia, Sleep fragmentation, Cardiovascular diseases, Cerebrovascular diseasesAbstract
Background: Obstructive sleep apnoea syndrome (OSAS) is a common sleep-related breathing disorder of multi-risk factorial pathogenesis and is characterized by recurrent, partial or complete upper airway obstruction resulting in intermittent hypoxia during sleep. It has been implicated in both cardiovascular and cerebrovascular diseases. Objective of the study was to determine the association of Plasma Fibrinogen levels with the severity of OSA patients in a tertiary care hospital.
Methods: This cross-sectional observational study with group comparison was conducted among all the patients attending in the Department of Respiratory Medicine, BSMMU with suspicion of OSA within one year after the clearance of institutional review board (IRB) using STOP-BANG questionnaire and Epworth sleepiness scale (ESS) and confirmed by polysomnography. Plasma fibrinogen was measured in all OSA and non-OSA patients. Data were analyzed with the help of statistical package for the social sciences (SPSS) version 26.
Results: Sociodemographic analysis found no significant differences in age, gender, area, occupation, or smoking between OSA and non-OSA groups (p>0.05). However, witnessed apnoea (p=0.002), breathlessness (p=0.005), higher ESS (p<0.001), and STOP-Bang scores (p<0.001) were associated with OSA. Plasma fibrinogen levels were significantly higher in OSA (319.2±63.7 mg/dl versus 242.5±20.33 mg/dl, p<0.001), positively correlating with AHI (r=+0.876, p=0.001). Positive correlations were also found between fibrinogen levels and daytime sleepiness (r= +0.393, p=0.002), waist circumference (r =+0.346, p=0.007), and BMI (r =+0.297, p=0.021) in OSA patients.
Conclusions: In conclusion, this study establishes a notable connection between plasma fibrinogen levels and the severity of OSA. Elevated fibrinogen levels correlate with increased OSA severity, indicating a link between OSA, inflammation and coagulation.
Metrics
References
De Backer W. Obstructive sleep apnea/hypopnea syndrome. Panminerva Med. 2013;55(2):191-5.
Mosharraf-Hossain AK, Ahmed K, Islam MT, Chakrabortty R. A Community study of obstructive sleep apnea hypopnea syndrome (OSAHS) in middle-aged Bangladeshi population. Bangladesh Med Res Counc Bull. 2015;41(1):13-8.
Asada Y, Yamashita A, Sato Y, Hatakeyama K. Thrombus Formation and Propagation in the Onset of Cardiovascular Events. J Atheroscler Thromb. 2018;25(8):653-64.
Anker SD, von Haehling S, Germany R. Sleep-disordered breathing and cardiovascular disease. Indian Heart J. 2016;68:S69-76.
Archontogeorgis K, Voulgaris A, Papanas N, Nena E, Froudarakis M, Mikhailidis DP, et al. Mean Platelet Volume and Platelet Distribution Width in Patients With Obstructive Sleep Apnea Syndrome and Concurrent Chronic Obstructive Pulmonary Disease. Clin Appl Thromb Hemost. 2018;24(8):1216-22.
Basoglu OK, Sarac F, Sarac S, Uluer H, Yilmaz C. Metabolic syndrome, insulin resistance, fibrinogen, homocysteine, leptin, and C-reactive protein in obese patients with obstructive sleep apnea syndrome. Ann Thorac Med. 2011;6(3):120-5.
Baguet JP, Hammer L, Lévy P, Pierre H, Rossini E, Mouret S, et al. Night-time and diastolic hypertension are common and underestimated conditions in newly diagnosed apnoeic patients. J Hypertens. 2005;23(3):521-7.
Berge T, Lyngbakken MN, Ihle-Hansen H, Brynildsen J, Pervez MO, Aagaard EN, et al. Prevalence of atrial fibrillation and cardiovascular risk factors in a 63-65 years old general population cohort: the Akershus Cardiac Examination (ACE) 1950 Study. BMJ Open. 2018;8(7):e021704.
Chung F, Liao P, Sun Y, Amirshahi B, Fazel H, Shapiro CM, et al. Perioperative practical experiences in using a level 2 portable polysomnography. Sleep Breath. 2011;15(3):367-75.
Lisabeth LD, Sánchez BN, Lim D, Chervin RD, Case E, Morgenstern LB, Tower S, Brown DL. Sleep-disordered breathing and poststroke outcomes. Ann Neurol. 2019;86(2):241-50.
Meade TW, North WR, Chakrabarti R, Stirling Y, Haines AP, Thompson SG, et al. Haemostatic function and cardiovascular death: early results of a prospective study. Lancet. 1980;1(8177):1050-4.
Mohammadieh A, Sutherland K, Cistulli PA. Sleep disordered breathing: management update. Intern Med J. 2017;47(11):1241-7.
Mohsenin V. Gender differences in the expression of sleep- disordered breathing: role of upper airway dimensions. Chest. 2001;120(5):1442-7.
Morrell MJ, Finn L, McMillan A, Peppard PE. The impact of ageing and sex on the association between sleepiness and sleep disordered breathing. Eur Respir J. 2012;40(2):386-93.
Naji DH, Tan C, Han F, Zhao Y, Wang J, Wang D, et al. Significant genetic association of a functional TFPI variant with circulating fibrinogen levels and coronary artery disease. Mol Genet Genomics. 2018;293(1):119-28.
Sanders MH, Givelber R. Sleep disordered breathing may not be an independent risk factor for diabetes, but diabetes may contribute to the occurrence of periodic breathing in sleep. Sleep Med. 2003;4(4):349-50.
Slater G, Pengo MF, Kosky C, Steier J. Obesity as an independent predictor of subjective excessive daytime sleepiness. Respir Med. 2013;107(2):305-9.
Morrell MJ, Finn L, McMillan A, Peppard PE. The impact of ageing and sex on the association between sleepiness and sleep disordered breathing. Eur Respir J. 2012;40(2):386-93.
Peppard PE, Young T, Palta M, Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med. 2000;342(19):1378-84.
Marin, J.M., Agusti, A., Villar, I., Forner, M., Nieto, D., Carrizo, S.J., Barbé, F., Vicente, E., Wei, Y., Nieto, F.J. and Jelic, S., 2012. Association between treated and untreated obstructive sleep apnea and risk of hypertension. Jama, 307(20), pp.2169-2176.
Haentjens P, Van Meerhaeghe A, Moscariello A, De Weerdt S, Poppe K, Dupont A, et al. The impact of continuous positive airway pressure on blood pressure in patients with obstructive sleep apnea syndrome: evidence from a meta-analysis of placebo-controlled randomized trials. Arch Intern Med. 2007;167(8):757-64.
Young T, Peppard PE, Gottlieb DJ. Epidemiology of obstructive sleep apnea: a population health perspective. Am J Respir Crit Care Med. 2002;165(9):1217-39.
Celikhisar H, Ilkhan GD. Assessment of fibrinogen levels in obstructive sleep apnea patients. Med Sci. 2021;10(3):770-4.
Lattimore JDL, Celermajer DS, Wilcox I. Obstructive sleep apnea and cardiovascular disease. J Am Coll Cardiol. 2003;41(9):1429-37.
Marshall NS, Wong KK, Cullen SR, Knuiman MW, Grunstein RR. Sleep apnea and 20-year follow-up for all-cause mortality, stroke, and cancer incidence and mortality in the Busselton Health Study cohort. J Clin Sleep Med. 2014;10(4):355-62.
Xiao Y, Yang LR, Zhu GF, Zhang Y, Wu CT, Zhang WM. Effect of obstructive sleep apnea on the severity of acute pulmonary thromboembolism. Zhonghua Yi Xue Za Zhi. 2019;99(10):739-43.
Yang G, Cun L, Ma Y, Duan J. Analysis of bleeding cause after uvulopalatopharyngoplasty with endotherm knife. Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2015;29(19):1710-2.
Xiao Y, Yang LR, Zhu GF, Zhang Y, Wu CT, Zhang WM. Effect of obstructive sleep apnea on the severity of acute pulmonary thromboembolism. Zhonghua Yi Xue Za Zhi. 2019;99(10):739-43.
Bouloukaki I, Mermigkis C, Tzanakis N, Kallergis E, Moniaki V, Mauroudi E, et al. Evaluation of Inflammatory Markers in a Large Sample of Obstructive Sleep Apnea Patients without Comorbidities. Mediators Inflamm. 2017;2017:4573756.